Alternative Injectable Opioids When Injectable Morphine is Unavailable

Primary Injectable Alternatives

The British medical community recommends hydromorphone as a preferred alternative for parenteral administration because it is 5-10 times more potent than morphine and significantly more soluble, allowing smaller injection volumes 2, 4
For a patient on oral morphine 10mg every 4 hours, convert to approximately 20mg/day parenteral morphine equivalent, then calculate hydromorphone dose at 1/7th to 1/10th of this amount 4
Hydromorphone has similar efficacy and adverse effect profile to morphine when used in equianalgesic doses 4
Diamorphine is the preferred injectable opioid in Britain due to considerably greater solubility than morphine, ensuring injection volumes remain small 1, 2

Divide the total daily oral morphine dose by 3 to obtain the parenteral equivalent dose, then adjust upward or downward based on individual response 1, 2, 3
For oral morphine 10mg every 4 hours, the parenteral equivalent dose is approximately 20mg/day, which converts to roughly 3-4mg subcutaneous every 4 hours as starting dose 1, 2

Subcutaneous administration is strongly preferred over intramuscular because it is simpler, less painful, requires smaller needles, and has similar absorption with peak plasma concentrations within 15-30 minutes 1, 2, 5
Intravenous administration should be reserved for patients with existing IV access, generalized edema, coagulation disorders, poor peripheral circulation, or problems with subcutaneous sites 2, 5

Rectal morphine has 1:1 bioavailability with oral morphine, meaning the same 10mg dose every 4 hours can be used rectally with equivalent duration of effect 2, 3, 5
Transdermal fentanyl is recommended as a useful non-invasive alternative for patients with stable opioid requirements, though it is less flexible than shorter-acting preparations 2, 4

The oral to parenteral potency ratio varies between 1:2 and 1:3 depending on individual patient factors—always start conservatively and titrate based on response 1, 2, 3
Do not use intramuscular administration for chronic pain—it offers no advantage and causes more pain than subcutaneous 1, 2, 5
Reassess pain control and adverse effects within 15-30 minutes for subcutaneous/IV routes versus 1 hour for oral routes 1, 5, 6